BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19958818)

  • 1. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
    Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
    Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
    Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
    Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model.
    Harter PN; Dützmann S; Drott U; Zachskorn C; Hattingen E; Capper D; Gessler F; Senft C; Seifert V; Plate KH; Kögel D; Mittelbronn M
    Neuropathology; 2013 Oct; 33(5):515-25. PubMed ID: 23384223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
    Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
    Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
    Collier ME; Li C; Ettelaie C
    Mol Cancer Res; 2008 Dec; 6(12):1807-18. PubMed ID: 19074826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB; Haugland HK; Bjerkvig R
    Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way.
    Brousseau C; Morissette G; Fortin JP; Marceau F; Petitclerc E
    Can J Physiol Pharmacol; 2009 Sep; 87(9):694-701. PubMed ID: 19794520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
    Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.
    Gao L; Smith RS; Chen LM; Chai KX; Chao L; Chao J
    Biol Chem; 2010 Jul; 391(7):803-12. PubMed ID: 20482314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.
    Provençal M; Labbé D; Veitch R; Boivin D; Rivard GE; Sartelet H; Robitaille Y; Gingras D; Béliveau R
    Carcinogenesis; 2009 Jul; 30(7):1089-96. PubMed ID: 19359592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.